Variant report

Variant	nsv975171
Chromosome Location	chr11:47209667-47215620
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:284)
CpG islands
(count:245)
Chromatin interactive
region (count:28)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:284 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:47215398-47215734	HepG2	liver:	n/a	n/a
2	ARID3A	chr11:47210783-47211422	HepG2	liver:	n/a	n/a
3	BCL3	chr11:47210745-47211490	A549	lung:	n/a	n/a
4	BHLHE40	chr11:47210857-47211397	HepG2	liver:	n/a	n/a
5	BHLHE40	chr11:47210971-47211248	K562	blood:	n/a	n/a
6	BRCA1	chr11:47215523-47216029	Hela-S3	cervix:	n/a	n/a
7	BRCA1	chr11:47210899-47211190	HepG2	liver:	n/a	n/a
8	BRCA1	chr11:47210824-47211379	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr11:47210844-47211262	HepG2	liver:	n/a	n/a
10	CEBPB	chr11:47210612-47211365	A549	lung:	n/a	n/a
11	CEBPB	chr11:47210572-47211493	MCF-7	breast:	n/a	n/a
12	CEBPB	chr11:47215517-47216088	MCF-7	breast:	n/a	n/a
13	CEBPB	chr11:47210647-47210819	K562	blood:	n/a	n/a
14	CEBPB	chr11:47210584-47211361	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr11:47210644-47211641	HepG2	liver:	n/a	n/a
16	CEBPB	chr11:47210623-47211456	MCF-7	breast:	n/a	n/a
17	CEBPB	chr11:47210624-47211464	A549	lung:	n/a	n/a
18	CEBPB	chr11:47210636-47211651	A549	lung:	n/a	n/a
19	CEBPB	chr11:47210647-47211621	HepG2	liver:	n/a	n/a
20	CEBPB	chr11:47210595-47211643	IMR90	lung:	n/a	n/a
21	CEBPB	chr11:47210671-47210829	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr11:47211488-47211633	HepG2	liver:	n/a	n/a
23	CEBPB	chr11:47215400-47216015	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr11:47211492-47211620	K562	blood:	n/a	n/a
25	CEBPB	chr11:47210894-47211268	HepG2	liver:	n/a	n/a
26	CHD2	chr11:47210847-47211248	Hela-S3	cervix:	n/a	n/a
27	CREB1	chr11:47210910-47211101	A549	lung:	n/a	n/a
28	CTCF	chr11:47213961-47214013	GM13976	blood:	n/a	n/a
29	E2F4	chr11:47210881-47211168	MCF10A-Er-Src	breast:	n/a	n/a
30	E2F4	chr11:47215482-47215590	MCF10A-Er-Src	breast:	n/a	n/a
31	ELF1	chr11:47210877-47211207	HepG2	liver:	n/a	n/a
32	ELF1	chr11:47215484-47216150	MCF-7	breast:	n/a	n/a
33	ELF1	chr11:47215498-47216082	MCF-7	breast:	n/a	n/a
34	ELF1	chr11:47210805-47211278	HepG2	liver:	n/a	n/a
35	ELK1	chr11:47215559-47216030	Hela-S3	cervix:	n/a	n/a
36	ELK4	chr11:47215575-47215987	Hela-S3	cervix:	n/a	n/a
37	EP300	chr11:47209326-47210279	SK-N-SH_RA	brain:	n/a	n/a
38	EP300	chr11:47207858-47210318	SK-N-SH	brain:	n/a	chr11:47208078-47208094 chr11:47208901-47208917
39	EP300	chr11:47215546-47216018	T-47D	breast:	n/a	n/a
40	EP300	chr11:47210709-47211469	A549	lung:	n/a	n/a
41	EP300	chr11:47215324-47215753	HepG2	liver:	n/a	n/a
42	EP300	chr11:47210656-47211485	A549	lung:	n/a	n/a
43	EP300	chr11:47215436-47215636	HepG2	liver:	n/a	n/a
44	EP300	chr11:47209595-47209683	GM12878	blood:	n/a	n/a
45	EP300	chr11:47210785-47211346	HepG2	liver:	n/a	n/a
46	EP300	chr11:47215450-47216084	T-47D	breast:	n/a	n/a
47	EP300	chr11:47210841-47211188	SK-N-SH_RA	brain:	n/a	n/a
48	EP300	chr11:47209327-47210221	SK-N-SH_RA	brain:	n/a	n/a
49	EP300	chr11:47210680-47211351	HepG2	liver:	n/a	n/a
50	EP300	chr11:47210624-47211426	T-47D	breast:	n/a	n/a

(count:245 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:47213196-47213246	HIPEpiC	eye:	n/a
2	chr11:47213196-47213246	HIPEpiC	eye:	n/a
3	chr11:47213075-47213125	IMR90	lung:	fetal
4	chr11:47213116-47213166	HAEpiC	amniotic membrane:	n/a
5	chr11:47213075-47213125	ovcar-3	ovarian:	n/a
6	chr11:47211048-47211098	HPAEpiC	pulmonary alveolar:	n/a
7	chr11:47211048-47211098	BE2_C	brain:	n/a
8	chr11:47213116-47213166	ProgFib	skin:	n/a
9	chr11:47213075-47213125	NB4	blood:	n/a
10	chr11:47213116-47213166	HEEpiC	esophagus:	n/a
11	chr11:47213196-47213246	T-47D	breast:	n/a
12	chr11:47211048-47211098	SKMC	muscle:	n/a
13	chr11:47211048-47211098	ProgFib	skin:	n/a
14	chr11:47213116-47213166	HMEC	breast:	n/a
15	chr11:47213116-47213166	GM12891	blood:	n/a
16	chr11:47211048-47211098	HRCEpiC	kidney:	n/a
17	chr11:47211048-47211098	GM12892	blood:	n/a
18	chr11:47211048-47211098	NB4	blood:	n/a
19	chr11:47213196-47213246	HL-60	blood:	n/a
20	chr11:47213116-47213166	Hela-S3	cervix:	n/a
21	chr11:47213116-47213166	AoSMC	blood vessel:	n/a
22	chr11:47213075-47213125	PANC-1	pancreas:	n/a
23	chr11:47211048-47211098	HNPCEpiC	eye:	n/a
24	chr11:47213196-47213246	HCF	heart:	n/a
25	chr11:47213075-47213125	BE2_C	brain:	n/a
26	chr11:47213075-47213125	PrEC	prostate:	n/a
27	chr11:47213075-47213125	HCM	heart:	n/a
28	chr11:47213116-47213166	NHDF-neo	bronchial:	n/a
29	chr11:47211048-47211098	Caco-2	colon:	n/a
30	chr11:47213116-47213166	BJ	skin:	n/a
31	chr11:47211048-47211098	H1-hESC	embryonic stem cell:	embryo
32	chr11:47213116-47213166	NT2-D1	testis:	n/a
33	chr11:47213196-47213246	ovcar-3	ovarian:	n/a
34	chr11:47211048-47211098	Hela-S3	cervix:	n/a
35	chr11:47213196-47213246	IMR90	lung:	fetal
36	chr11:47213196-47213246	AG04450	lung:	fetal
37	chr11:47213075-47213125	HRE	kidney:	n/a
38	chr11:47213116-47213166	PANC-1	pancreas:	n/a
39	chr11:47211048-47211098	HEEpiC	esophagus:	n/a
40	chr11:47213075-47213125	MCF10A-Er-Src	breast:	n/a
41	chr11:47211048-47211098	AG09309	skin:	n/a
42	chr11:47213116-47213166	ovcar-3	ovarian:	n/a
43	chr11:47213075-47213125	SK-N-MC	brain:	n/a
44	chr11:47213116-47213166	MCF-7	breast:	n/a
45	chr11:47213196-47213246	HRE	kidney:	n/a
46	chr11:47211048-47211098	HCPEpiC	choroid plexus:	n/a
47	chr11:47213196-47213246	NH-A	brain:	n/a
48	chr11:47213116-47213166	ECC-1	luminal epithelium:	n/a
49	chr11:47211048-47211098	HUVEC	blood vessel:	n/a
50	chr11:47213196-47213246	HepG2	liver:	n/a

(count:28 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:47209972..47212228-chr11:47292930..47294669,2	MCF-7	breast:
2	chr11:47214452..47216004-chr11:47218077..47220648,2	MCF-7	breast:
3	chr11:47209261..47211056-chr11:47214428..47216571,3	K562	blood:
4	chr11:47209362..47211566-chr11:47254961..47257621,2	MCF-7	breast:
5	chr11:47209261..47211056-chr11:47214428..47216571,3	K562	blood:
6	chr11:47208178..47210711-chr11:47292129..47294410,2	K562	blood:
7	chr11:47205341..47210329-chr11:47212095..47213798,5	MCF-7	breast:
8	chr11:47208035..47210761-chr11:47215071..47216625,2	K562	blood:
9	chr11:47208035..47210761-chr11:47215071..47216625,2	K562	blood:
10	chr11:47208508..47211092-chr11:47245771..47247789,2	MCF-7	breast:
11	chr11:47214149..47216188-chr11:47236572..47238228,2	K562	blood:
12	chr11:47214523..47217185-chr11:47223816..47226023,3	MCF-7	breast:
13	chr11:47202119..47205492-chr11:47206060..47209673,5	K562	blood:
14	chr11:47215549..47217422-chr11:47236741..47239012,3	MCF-7	breast:
15	chr11:47206234..47211366-chr11:47214484..47221177,8	MCF-7	breast:
16	chr11:47205635..47209843-chr11:47268961..47271979,7	MCF-7	breast:
17	chr11:47210760..47211699-chr11:47264854..47265597,2	MCF-7	breast:
18	chr11:47197346..47199498-chr11:47214509..47216366,2	MCF-7	breast:
19	chr11:47205110..47208888-chr11:47209275..47211677,6	MCF-7	breast:
20	chr11:47213506..47215073-chr11:47222663..47225533,2	MCF-7	breast:
21	chr11:47204023..47207155-chr11:47207314..47211225,4	K562	blood:
22	chr11:47205217..47215436-chr11:47233934..47241095,26	MCF-7	breast:
23	chr11:47205837..47210171-chr11:47289770..47293955,7	MCF-7	breast:
24	chr11:47215606..47218098-chr11:47271095..47273524,2	MCF-7	breast:
25	chr11:47206281..47210029-chr11:47290997..47292963,3	K562	blood:
26	chr11:47205341..47210329-chr11:47212095..47213798,5	MCF-7	breast:
27	chr11:47205689..47216568-chr11:47232414..47239487,27	MCF-7	breast:
28	chr11:47207085..47210178-chr11:47288214..47292056,4	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000243802	TF binding region
PACSIN3	TF binding region
ENSG00000243802	CpG island
PACSIN3	CpG island
ENSG00000243802	chromatin interactions
ENSG00000110514	chromatin interactions
ENSG00000256746	chromatin interactions
ENSG00000165912	chromatin interactions
ENSG00000025434	chromatin interactions
ENSG00000134575	chromatin interactions
ENSG00000149182	chromatin interactions
ENSG00000134574	chromatin interactions

Extended variants
information (count: 201 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:201 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs375828799	chr11:47209714-47209715	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
2	rs146444584	chr11:47209715-47209716	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
3	rs538695663	chr11:47209723-47209724	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
4	rs565938378	chr11:47209870-47209871	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
5	rs531061834	chr11:47209939-47209940	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
6	rs146362341	chr11:47209979-47209980	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
7	rs550871627	chr11:47210016-47210017	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
8	rs560769035	chr11:47210036-47210037	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
9	rs574319776	chr11:47210195-47210196	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
10	rs567312210	chr11:47210219-47210220	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
11	rs77791026	chr11:47210259-47210260	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs200275688	chr11:47210262-47210263	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
13	rs369929916	chr11:47210281-47210282	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
14	rs530136243	chr11:47210316-47210317	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
15	rs540031247	chr11:47210360-47210361	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs550308118	chr11:47210403-47210404	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs190159673	chr11:47210406-47210407	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs557936701	chr11:47210422-47210423	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs571475041	chr11:47210469-47210470	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs140670506	chr11:47210485-47210486	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs560235272	chr11:47210516-47210517	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs532389965	chr11:47210523-47210524	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs181408744	chr11:47210528-47210529	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs573537738	chr11:47210637-47210638	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs534850149	chr11:47210648-47210649	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs542644218	chr11:47210679-47210680	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs552711086	chr11:47210680-47210681	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs545491824	chr11:47210687-47210688	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs377482012	chr11:47210713-47210714	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs544708528	chr11:47210732-47210733	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs565097022	chr11:47210913-47210914	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs531051443	chr11:47210920-47210921	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs186486855	chr11:47210942-47210943	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs189358470	chr11:47210943-47210944	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs530342740	chr11:47210989-47210990	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs145790782	chr11:47211019-47211020	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs566753349	chr11:47211030-47211031	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs116450863	chr11:47211048-47211049	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs552742230	chr11:47211049-47211050	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs556340988	chr11:47211093-47211094	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs571460965	chr11:47211102-47211103	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs537274830	chr11:47211116-47211117	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs557279826	chr11:47211205-47211206	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs567520025	chr11:47211209-47211210	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs536179807	chr11:47211243-47211244	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs138497353	chr11:47211304-47211305	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs572761265	chr11:47211310-47211311	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs370342782	chr11:47211336-47211337	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs544696106	chr11:47211382-47211383	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs558277405	chr11:47211505-47211506	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Parathyroid adenoma	22454399	CNVD
Medulloblastoma	21979893	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Medulloblastoma	16783165	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Chordoma	18071362	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
small cell lung cancer	20016488	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Intracranial ependymoma	16609018	CNVD
Myxofibrosarcoma	16751306	CNVD
Potocki-Shaffer syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Breast cancer	20409316	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ependymoma	20639864	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Cancer	17440070	CNVD

Chromatin state (count:206 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:47206000-47210000	Flanking Active TSS	Stomach Smooth Muscle	stomach
2	chr11:47208200-47209800	Flanking Active TSS	Hela-S3	cervix
3	chr11:47208200-47210200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
4	chr11:47208600-47209800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr11:47208600-47211600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr11:47208800-47210400	Enhancers	Fetal Lung	lung
7	chr11:47209000-47211600	Enhancers	Liver	Liver
8	chr11:47209200-47209800	Enhancers	GM12878-XiMat	blood
9	chr11:47209200-47209800	Flanking Active TSS	Osteobl	bone
10	chr11:47209200-47210000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr11:47209200-47210000	Flanking Active TSS	HepG2	liver
12	chr11:47209200-47210200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
13	chr11:47209200-47210200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
14	chr11:47209200-47210200	Enhancers	A549	lung
15	chr11:47209200-47211400	Enhancers	Placenta Amnion	Placenta Amnion
16	chr11:47209200-47211400	Enhancers	NHDF-Ad	bronchial
17	chr11:47209200-47211800	Enhancers	Placenta	Placenta
18	chr11:47209200-47216000	Weak transcription	Esophagus	oesophagus
19	chr11:47209400-47209800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr11:47209400-47209800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr11:47209400-47209800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
22	chr11:47209400-47209800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
23	chr11:47209400-47209800	Enhancers	Muscle Satellite Cultured Cells	--
24	chr11:47209400-47209800	Enhancers	Cortex derived primary cultured neurospheres	brain
25	chr11:47209400-47209800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr11:47209400-47209800	Enhancers	Brain Cingulate Gyrus	brain
27	chr11:47209400-47209800	Weak transcription	Lung	lung
28	chr11:47209400-47209800	Enhancers	HSMMtube	muscle
29	chr11:47209400-47209800	Enhancers	NH-A	brain
30	chr11:47209400-47210000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr11:47209400-47210000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr11:47209400-47210000	Enhancers	Rectal Smooth Muscle	rectum
33	chr11:47209400-47210200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr11:47209400-47210200	Enhancers	Brain Inferior Temporal Lobe	brain
35	chr11:47209400-47210200	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
36	chr11:47209400-47210600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr11:47209400-47210600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr11:47209400-47210600	Weak transcription	Psoas Muscle	Psoas
39	chr11:47209400-47210800	Weak transcription	HMEC	breast
40	chr11:47209400-47211000	Enhancers	Left Ventricle	heart
41	chr11:47209400-47211000	Weak transcription	Right Atrium	heart
42	chr11:47209400-47211400	Enhancers	Fetal Kidney	kidney
43	chr11:47209400-47211600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr11:47209400-47211600	Enhancers	Fetal Intestine Large	intestine
45	chr11:47209400-47211600	Enhancers	Fetal Intestine Small	intestine
46	chr11:47209400-47213800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
47	chr11:47209600-47209800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
48	chr11:47209600-47209800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
49	chr11:47209600-47209800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
50	chr11:47209600-47209800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links